This study will determine the influence of methylphenidate (e.g., Ritalin®) and duloxetine (Cymbalta®), alone and in combination, on the cocaine use as measured by self-report and urine drug screens.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
TRIPLE
Enrollment
13
The pharmacodynamic effects of methylphenidate maintenance will be determined during maintenance on placebo and duloxetine.
The pharmacodynamic effects of placebo will be determined during maintenance on placebo and duloxetine.
The pharmacodynamic effects of duloxetine will be determined during maintenance on placebo and methylphenidate
University of Kentucky Medical Center
Lexington, Kentucky, United States
Number of Cocaine Positive Urines
Cocaine use will be assessed using qualitative urine drug screens over a six week period.
Time frame: Six weeks
Self-Reported Cocaine Use
Cocaine use will be assessed using self-report on the Time Line Follow Back over a six week period.
Time frame: Six weeks
Blood Pressure
Blood Pressure in mmHG will be measured on each week day over a six week period.
Time frame: Six weeks
Heart Rate
Heart Rate in beats per minute will be measured on each week day over a six week period.
Time frame: Six weeks
Side effects
Subjects will complete a side effects questionnaire on each week day over a six week period. Side Effects questions will query subjects about common effects of centrally active medications.
Time frame: Six weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.